Updates

New articles, approval and society announcements and newly registered clinical trials in nuclear medicine, each with its source. Article and announcement summaries are written by AI from the published text; featured pieces are approved by the physician editor.

Radiopharmaceutical approval timeline →

Every Monday in your inbox: the week's new articles and a short synthesis in the topics you choose (PSMA, NET, thyroid, cardiac…). Free with an account, one click to turn off. Choose your topics →

FeaturedDoes the tumour absorbed dose predict survival with Lu-177 DOTATATE?A post hoc analysis of the Swedish phase 2 ILUMINET trial (Warfvinge et al., J Nucl Med, October 2026) reported that, in 81 patients with grade 1-2 neuroendocrine tumours treated with [177Lu]Lu-DOTATATE, the mean absorbed dose to the whole tumour burden was independently associated with progression-free and overall survival. This article summarises the study, how the dose was measured, and earlier studies that asked the same question.Read the piece →FeaturedTotal tumour volume on PSMA PET: predicting survival with a single numberThe latest analysis of the PROMISE PET Registry, covering 13,893 patients (Karpinski et al., J Nucl Med, November 2026), reported that among the quantifiable PSMA PET metrics, PSMA-positive total tumour volume (PSMA TTV) best predicted overall survival. This article summarises the study, what the measurement is, and how it relates to the same group's earlier risk tools.Read the piece →FeaturedDoes giving Lu-177 DOTATATE through the hepatic artery make a difference in liver metastases?The idea is circulating again on social media: giving the radiopeptide through a catheter in the hepatic artery instead of a vein. This article reviews four studies. LUTIA (Ebbers et al., the Netherlands, 2023-2024), the only randomised trial on the question, found no clinically meaningful increase in tumour uptake; Bodei et al. (Memorial Sloan Kettering, New York), published in November 2026, reported in a 10-patient prospective study a more than threefold higher dose to liver metastases by combining the arterial and intravenous routes in sequence.Read the piece →

Loading…

Sources we follow

The feed is compiled automatically from these sources every day; every item links to its original.

  1. Societies

    News and press releases; administrative notices such as meetings, registration and awards are left out.

    1. EANM – European Association of Nuclear Medicine · News
    2. SNMMI – Society of Nuclear Medicine and Molecular Imaging · News and press releases
    3. ASNC – American Society of Nuclear Cardiology · Updates
    4. TNTD – Türkiye Nükleer Tıp Derneği · Society news and notices
    5. SEMNIM – Sociedad Española de Medicina Nuclear e Imagen Molecular · News (Spanish; summarised in English and Turkish)
    6. AIMN – Associazione Italiana di Medicina Nucleare · News (Italian; summarised in English and Turkish)
  2. Related societies

    Only items relevant to nuclear medicine (radioiodine, scintigraphy, PET).

    1. ATA – American Thyroid Association · News and journal highlights
  3. Regulators

    Only announcements relevant to nuclear medicine (radiopharmaceutical approvals, safety notices).

    1. FDA – U.S. Food and Drug Administration · Press announcements
    2. EMA – European Medicines Agency · News (including CHMP opinions)
    3. IAEA – International Atomic Energy Agency · News centre
    4. TİTCK – Türkiye İlaç ve Tıbbi Cihaz Kurumu · Announcements (radiopharmaceutical licensing, supply, recalls)
  4. Literature

    PubMed is searched daily: 13 topic queries and every new article in the core journals below. The RSS feeds of JNM and Elsevier journals are also read daily; each article is matched to its PubMed record (DOI or PII), so no article appears twice. Summaries are written by AI from the published abstract.

    1. PubMed (U.S. National Library of Medicine) · 13 topic queries
    2. The Journal of Nuclear Medicine – RSS · Ahead-of-print articles (RSS)
    3. Seminars in Nuclear Medicine – RSS · Elsevier RSS feed
    4. Journal of Nuclear Cardiology – RSS · Elsevier RSS feed
    5. Nuclear Medicine and Biology – RSS · Elsevier RSS feed
    6. The Journal of Nuclear Medicine
    7. European Journal of Nuclear Medicine and Molecular Imaging
    8. Clinical Nuclear Medicine
    9. Seminars in Nuclear Medicine
    10. Journal of Nuclear Cardiology
    11. EJNMMI Research
    12. EJNMMI Physics
    13. EJNMMI Radiopharmacy and Chemistry
    14. Journal of Nuclear Medicine Technology
    15. Nuclear Medicine and Biology
    16. Molecular Imaging and Biology
    17. Annals of Nuclear Medicine
    18. Nuclear Medicine Communications
    19. Theranostics
    20. The Quarterly Journal of Nuclear Medicine and Molecular Imaging
    21. Nuklearmedizin – NuclearMedicine
    22. Molecular Imaging and Radionuclide Therapy
    23. EJNMMI Reports
    24. European Journal of Hybrid Imaging
    25. Nuclear Medicine and Molecular Imaging
    26. World Journal of Nuclear Medicine
    27. Indian Journal of Nuclear Medicine
    28. Asia Oceania Journal of Nuclear Medicine and Biology
    29. Revista Española de Medicina Nuclear e Imagen Molecular
    30. Hellenic Journal of Nuclear Medicine
    31. Nuclear Medicine Review
    32. Frontiers in Nuclear Medicine
    33. Cancer Biotherapy and Radiopharmaceuticals
    34. Journal of Labelled Compounds and Radiopharmaceuticals
  5. Preprints

    Studies not yet peer reviewed; labelled separately, nuclear medicine only.

    1. medRxiv · First versions from the last 7 days
  6. Clinical trials

    Newly registered radiopharmaceutical and theranostic trials; the official registry record and a short bilingual summary of it.

    1. ClinicalTrials.gov · New registrations
  7. Reference sources we link to

    1. Radiopaedia · Cases and reference articles; content is CC BY-NC-SA, linked only
    2. OpenEvidence · Evidence search; no public feed, linked only
    3. BNMS – British Nuclear Medicine Society · No readable feed; linked
    4. DGN – Deutsche Gesellschaft für Nuklearmedizin · No readable feed; linked
    5. SFMN – Société Française de Médecine Nucléaire · No readable feed; linked
    6. ANZSNM – Australian and New Zealand Society of Nuclear Medicine · No readable feed; linked
    7. CANM – Canadian Association of Nuclear Medicine · No readable feed; linked
    8. ACNM – American College of Nuclear Medicine · Feed is empty; linked
    9. JSNM – Japanese Society of Nuclear Medicine · Linked
    10. KSNM – Korean Society of Nuclear Medicine · Linked
    11. WFNMB – World Federation of Nuclear Medicine and Biology · A few dispatches a year; linked
    12. AOFNMB – Asia Oceania Federation of Nuclear Medicine and Biology · Notice board mostly meetings; linked
    13. EANM kılavuzları · In the guideline box at the end of each chapter
    14. SNMMI Procedure Standards · In the guideline box and report templates